Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.

Dong Y, Yu T, Ding L, Laurini E, Huang Y, Zhang M, Weng Y, Lin S, Chen P, Marson D, Jiang Y, Giorgio S, Pricl S, Liu X, Rocchi P, Peng L.

J Am Chem Soc. 2018 Nov 28;140(47):16264-16274. doi: 10.1021/jacs.8b10021. Epub 2018 Nov 1.

PMID:
30346764
2.

Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment.

Ziouziou H, Andrieu C, Laurini E, Karaki S, Fermeglia M, Oueslati R, Taieb D, Camplo M, Siri O, Pricl S, Katsogiannou M, Rocchi P.

Oncotarget. 2018 Jun 19;9(47):28797. doi: 10.18632/oncotarget.25683. eCollection 2018 Jun 19.

3.

Survival estimates and outcome predictors for shelter cats with feline panleukopenia virus infection.

Porporato F, Horzinek MC, Hofmann-Lehmann R, Ferri F, Gerardi G, Contiero B, Vezzosi T, Rocchi P, Auriemma E, Lutz H, Zini E.

J Am Vet Med Assoc. 2018 Jul 15;253(2):188-195. doi: 10.2460/javma.253.2.188.

PMID:
29963955
4.

PSMA-Targeted Radionuclide Therapy and Salivary Gland Toxicity: Why Does It Matter?

Taïeb D, Foletti JM, Bardiès M, Rocchi P, Hicks RJ, Haberkorn U.

J Nucl Med. 2018 May;59(5):747-748. doi: 10.2967/jnumed.118.207993. Epub 2018 Feb 9. No abstract available.

PMID:
29439016
5.

TCTP Has a Crucial Role in the Different Stages of Prostate Cancer Malignant Progression.

Baylot V, Karaki S, Rocchi P.

Results Probl Cell Differ. 2017;64:255-261. doi: 10.1007/978-3-319-67591-6_13.

PMID:
29149413
6.

Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment.

Ziouziou H, Andrieu C, Laurini E, Karaki S, Fermeglia M, Oueslati R, Taieb D, Camplo M, Siri O, Pricl S, Katsogiannou M, Rocchi P.

Oncotarget. 2017 Aug 24;8(44):77317-77329. doi: 10.18632/oncotarget.20469. eCollection 2017 Sep 29. Erratum in: Oncotarget. 2018 Jun 19;9(47):28797.

7.

Primary fibrosarcoma of the urinary bladder in a cat: follow-up after incomplete surgical excision.

Greci V, Rocchi PM, Sontuoso AF, Olivero D, Capasso A, Raiano V.

JFMS Open Rep. 2017 Jun 19;3(1):2055116917714881. doi: 10.1177/2055116917714881. eCollection 2017 Jan-Jun.

8.

Lipid-oligonucleotide conjugates improve cellular uptake and efficiency of TCTP-antisense in castration-resistant prostate cancer.

Karaki S, Benizri S, Mejías R, Baylot V, Branger N, Nguyen T, Vialet B, Oumzil K, Barthélémy P, Rocchi P.

J Control Release. 2017 Jul 28;258:1-9. doi: 10.1016/j.jconrel.2017.04.042. Epub 2017 May 1.

9.

Mastering Dendrimer Self-Assembly for Efficient siRNA Delivery: From Conceptual Design to In Vivo Efficient Gene Silencing.

Chen C, Posocco P, Liu X, Cheng Q, Laurini E, Zhou J, Liu C, Wang Y, Tang J, Col VD, Yu T, Giorgio S, Fermeglia M, Qu F, Liang Z, Rossi JJ, Liu M, Rocchi P, Pricl S, Peng L.

Small. 2016 Jul;12(27):3667-76. doi: 10.1002/smll.201503866. Epub 2016 May 31.

10.

Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity.

Pasero C, Gravis G, Guerin M, Granjeaud S, Thomassin-Piana J, Rocchi P, Paciencia-Gros M, Poizat F, Bentobji M, Azario-Cheillan F, Walz J, Salem N, Brunelle S, Moretta A, Olive D.

Cancer Res. 2016 Apr 15;76(8):2153-65. doi: 10.1158/0008-5472.CAN-15-1965. Epub 2016 Apr 5.

11.

The Eukaryotic Translation Initiation Factor 4E (eIF4E) as a Therapeutic Target for Cancer.

Karaki S, Andrieu C, Ziouziou H, Rocchi P.

Adv Protein Chem Struct Biol. 2015;101:1-26. doi: 10.1016/bs.apcsb.2015.09.001. Epub 2015 Oct 23. Review.

PMID:
26572974
12.

The hallmarks of castration-resistant prostate cancers.

Katsogiannou M, Ziouziou H, Karaki S, Andrieu C, Henry de Villeneuve M, Rocchi P.

Cancer Treat Rev. 2015 Jul;41(7):588-97. doi: 10.1016/j.ctrv.2015.05.003. Epub 2015 May 9. Review.

PMID:
25981454
13.

Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer.

Pasero C, Gravis G, Granjeaud S, Guerin M, Thomassin-Piana J, Rocchi P, Salem N, Walz J, Moretta A, Olive D.

Oncotarget. 2015 Jun 10;6(16):14360-73.

14.

Pneumopericardium, pneumomediastinum, pneumothorax and pneumoretroperitoneum complicating pulmonary metastatic carcinoma in a cat.

Greci V, Baio A, Bibbiani L, Caggiano E, Borgonovo S, Olivero D, Rocchi PM, Raiano V.

J Small Anim Pract. 2015 Nov;56(11):679-83. doi: 10.1111/jsap.12366. Epub 2015 May 11.

PMID:
25958888
15.

Hsp27 Inhibition with OGX-427 Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib and Chemotherapy.

Lelj-Garolla B, Kumano M, Beraldi E, Nappi L, Rocchi P, Ionescu DN, Fazli L, Zoubeidi A, Gleave ME.

Mol Cancer Ther. 2015 May;14(5):1107-16. doi: 10.1158/1535-7163.MCT-14-0866. Epub 2015 Mar 4.

16.

Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance.

Wei T, Chen C, Liu J, Liu C, Posocco P, Liu X, Cheng Q, Huo S, Liang Z, Fermeglia M, Pricl S, Liang XJ, Rocchi P, Peng L.

Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):2978-83. doi: 10.1073/pnas.1418494112. Epub 2015 Feb 23.

17.

Spontaneous pneumopericardium in a dog with bronchopulmonary disease complicated by pyothorax and pneumothorax.

Borgonovo S, Rocchi PM, Raiano V, Diana D, Greci V.

Can Vet J. 2014 Dec;55(12):1186-91.

18.

Heat shock protein 27 phosphorylation state is associated with cancer progression.

Katsogiannou M, Andrieu C, Rocchi P.

Front Genet. 2014 Oct 6;5:346. doi: 10.3389/fgene.2014.00346. eCollection 2014. Review.

19.

Promoting siRNA delivery via enhanced cellular uptake using an arginine-decorated amphiphilic dendrimer.

Liu X, Liu C, Zhou J, Chen C, Qu F, Rossi JJ, Rocchi P, Peng L.

Nanoscale. 2015 Mar 7;7(9):3867-75. doi: 10.1039/c4nr04759a.

PMID:
25283447
20.

The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targets.

Katsogiannou M, Andrieu C, Baylot V, Baudot A, Dusetti NJ, Gayet O, Finetti P, Garrido C, Birnbaum D, Bertucci F, Brun C, Rocchi P.

Mol Cell Proteomics. 2014 Dec;13(12):3585-601. doi: 10.1074/mcp.M114.041228. Epub 2014 Oct 2.

21.

Adaptive amphiphilic dendrimer-based nanoassemblies as robust and versatile siRNA delivery systems.

Liu X, Zhou J, Yu T, Chen C, Cheng Q, Sengupta K, Huang Y, Li H, Liu C, Wang Y, Posocco P, Wang M, Cui Q, Giorgio S, Fermeglia M, Qu F, Pricl S, Shi Y, Liang Z, Rocchi P, Rossi JJ, Peng L.

Angew Chem Int Ed Engl. 2014 Oct 27;53(44):11822-7. doi: 10.1002/anie.201406764. Epub 2014 Sep 12.

22.

Targeted delivery of Dicer-substrate siRNAs using a dual targeting peptide decorated dendrimer delivery system.

Liu X, Liu C, Chen C, Bentobji M, Cheillan FA, Piana JT, Qu F, Rocchi P, Peng L.

Nanomedicine. 2014 Nov;10(8):1627-36. doi: 10.1016/j.nano.2014.05.008. Epub 2014 Jun 3.

PMID:
24965758
23.

Influence of ovarian stimulation for IVF/ICSI on the antioxidant defence system and relationship to outcome.

Palini S, Benedetti S, Tagliamonte MC, De Stefani S, Primiterra M, Polli V, Rocchi P, Catalani S, Battistelli S, Canestrari F, Bulletti C.

Reprod Biomed Online. 2014 Jul;29(1):65-71. doi: 10.1016/j.rbmo.2014.03.010. Epub 2014 Mar 26.

PMID:
24813757
24.

TCTP as therapeutic target in cancers.

Acunzo J, Baylot V, So A, Rocchi P.

Cancer Treat Rev. 2014 Jul;40(6):760-9. doi: 10.1016/j.ctrv.2014.02.007. Epub 2014 Mar 2. Review.

PMID:
24650927
25.

Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.

Liu C, Liu X, Rocchi P, Qu F, Iovanna JL, Peng L.

Bioconjug Chem. 2014 Mar 19;25(3):521-32. doi: 10.1021/bc4005156. Epub 2014 Feb 11.

PMID:
24494983
26.

Regulation of the proapoptotic functions of prostate apoptosis response-4 (Par-4) by casein kinase 2 in prostate cancer cells.

de Thonel A, Hazoumé A, Kochin V, Isoniemi K, Jego G, Fourmaux E, Hammann A, Mjahed H, Filhol O, Micheau O, Rocchi P, Mezger V, Eriksson JE, Rangnekar VM, Garrido C.

Cell Death Dis. 2014 Jan 23;5:e1016. doi: 10.1038/cddis.2013.532.

27.

Hsp27 as a therapeutic target in cancers.

Acunzo J, Andrieu C, Baylot V, So A, Rocchi P.

Curr Drug Targets. 2014 Apr;15(4):423-31. Review.

PMID:
24138636
28.

Efficient delivery of therapeutic small nucleic acids to prostate cancer cells using ketal nucleoside lipid nanoparticles.

Luvino D, Khiati S, Oumzil K, Rocchi P, Camplo M, Barthélémy P.

J Control Release. 2013 Dec 28;172(3):954-61. doi: 10.1016/j.jconrel.2013.09.006. Epub 2013 Sep 13.

PMID:
24041711
29.

Structurally flexible triethanolamine-core poly(amidoamine) dendrimers as effective nanovectors to deliver RNAi-based therapeutics.

Liu X, Liu C, Catapano CV, Peng L, Zhou J, Rocchi P.

Biotechnol Adv. 2014 Jul-Aug;32(4):844-52. doi: 10.1016/j.biotechadv.2013.08.001. Epub 2013 Aug 9. Review.

PMID:
23938269
30.

Impact of siRNA overhangs for dendrimer-mediated siRNA delivery and gene silencing.

Posocco P, Liu X, Laurini E, Marson D, Chen C, Liu C, Fermeglia M, Rocchi P, Pricl S, Peng L.

Mol Pharm. 2013 Aug 5;10(8):3262-73. doi: 10.1021/mp400329g. Epub 2013 Jul 25.

PMID:
23841848
31.

Development of an ELISA detecting Tumor Protein 53-Induced Nuclear Protein 1 in serum of prostate cancer patients.

Saadi H, Seillier M, Sandi MJ, Peuget S, Kellenberger C, Gravis G, Dusetti NJ, Iovanna JL, Rocchi P, Amri M, Carrier A.

Results Immunol. 2013 May 28;3:51-6. doi: 10.1016/j.rinim.2013.05.002. eCollection 2013.

32.

Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer.

Baylot V, Katsogiannou M, Andrieu C, Taieb D, Acunzo J, Giusiano S, Fazli L, Gleave M, Garrido C, Rocchi P.

Mol Ther. 2012 Dec;20(12):2244-56. doi: 10.1038/mt.2012.155. Epub 2012 Aug 14.

33.

An amphiphilic dendrimer for effective delivery of small interfering RNA and gene silencing in vitro and in vivo.

Yu T, Liu X, Bolcato-Bellemin AL, Wang Y, Liu C, Erbacher P, Qu F, Rocchi P, Behr JP, Peng L.

Angew Chem Int Ed Engl. 2012 Aug 20;51(34):8478-84. doi: 10.1002/anie.201203920. Epub 2012 Jul 24.

PMID:
22829421
34.

A novel bitriazolyl acyclonucleoside endowed with dual antiproliferative and immunomodulatory activity.

Xia Y, Wang M, Demaria O, Tang J, Rocchi P, Qu F, Iovanna JL, Alexopoulou L, Peng L.

J Med Chem. 2012 Jun 14;55(11):5642-6. doi: 10.1021/jm300534u. Epub 2012 May 21.

PMID:
22578090
35.

Small heat shock proteins HSP27 (HspB1), αB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death.

Acunzo J, Katsogiannou M, Rocchi P.

Int J Biochem Cell Biol. 2012 Oct;44(10):1622-31. doi: 10.1016/j.biocel.2012.04.002. Epub 2012 Apr 13. Review.

PMID:
22521623
36.

An efficient mixed-ligand Pd catalytic system to promote C-N coupling for the synthesis of N-arylaminotriazole nucleosides.

Fan Y, Xia Y, Tang J, Ziarelli F, Qu F, Rocchi P, Iovanna JL, Peng L.

Chemistry. 2012 Feb 20;18(8):2221-5. doi: 10.1002/chem.201103918. Epub 2012 Jan 20.

PMID:
22266830
37.

Targeting heat shock factor 1 with a triazole nucleoside analog to elicit potent anticancer activity on drug-resistant pancreatic cancer.

Xia Y, Liu Y, Rocchi P, Wang M, Fan Y, Qu F, Iovanna JL, Peng L.

Cancer Lett. 2012 May 28;318(2):145-53. doi: 10.1016/j.canlet.2011.09.043. Epub 2012 Jan 20.

PMID:
22266185
38.

TP53INP1 as new therapeutic target in castration-resistant prostate cancer.

Giusiano S, Baylot V, Andrieu C, Fazli L, Gleave M, Iovanna JL, Taranger-Charpin C, Garcia S, Rocchi P.

Prostate. 2012 Sep 1;72(12):1286-94. doi: 10.1002/pros.22477. Epub 2011 Dec 27.

PMID:
22213058
39.

Efficient delivery of sticky siRNA and potent gene silencing in a prostate cancer model using a generation 5 triethanolamine-core PAMAM dendrimer.

Liu X, Liu C, Laurini E, Posocco P, Pricl S, Qu F, Rocchi P, Peng L.

Mol Pharm. 2012 Mar 5;9(3):470-81. doi: 10.1021/mp2006104. Epub 2012 Jan 20.

PMID:
22208617
40.

OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer.

Baylot V, Andrieu C, Katsogiannou M, Taieb D, Garcia S, Giusiano S, Acunzo J, Iovanna J, Gleave M, Garrido C, Rocchi P.

Cell Death Dis. 2011 Oct 20;2:e221. doi: 10.1038/cddis.2011.104.

41.

Targeting heat shock response pathways to treat pancreatic cancer.

Xia Y, Rocchi P, Iovanna JL, Peng L.

Drug Discov Today. 2012 Jan;17(1-2):35-43. doi: 10.1016/j.drudis.2011.09.016. Epub 2011 Oct 1. Review.

PMID:
21986108
42.

Active-targeted nanotherapy strategies for prostate cancer.

Katsogiannou M, Peng L, Catapano CV, Rocchi P.

Curr Cancer Drug Targets. 2011 Oct;11(8):954-65. Review.

PMID:
21861840
43.

A round robin exercise in archaeometry: analysis of a blind sample reproducing a seventeenth century pharmaceutical ointment.

Colombini MP, Modugno F, Gamberini MC, Rocchi M, Baraldi C, Deviese T, Stacey RJ, Orlandi M, Saliu F, Riedo C, Chiantore O, Sciutto G, Catelli E, Brambilla L, Toniolo L, Miliani C, Rocchi P, Bleton J, Baumer U, Dietemann P, Pojana G, Marras S.

Anal Bioanal Chem. 2011 Oct;401(6):1847-60. doi: 10.1007/s00216-011-5105-1. Epub 2011 Jun 11.

PMID:
21667062
44.

TP53INP1 overexpression in prostate cancer correlates with poor prognostic factors and is predictive of biological cancer relapse.

Giusiano S, Garcia S, Andrieu C, Dusetti NJ, Bastide C, Gleave M, Taranger-Charpin C, Iovanna JL, Rocchi P.

Prostate. 2012 Feb 1;72(2):117-28. doi: 10.1002/pros.21412. Epub 2011 May 2.

PMID:
21538421
45.

Development of an analytical protocol for a fast, sensitive and specific protein recognition in paintings by enzyme-linked immunosorbent assay (ELISA).

Palmieri M, Vagnini M, Pitzurra L, Rocchi P, Brunetti BG, Sgamellotti A, Cartechini L.

Anal Bioanal Chem. 2011 Mar;399(9):3011-23. doi: 10.1007/s00216-010-4308-1. Epub 2010 Dec 19.

PMID:
21170522
46.

Ligand-mediated highly effective and selective C-N coupling for synthesizing bioactive N-aryltriazole acyclonucleosides.

Fan Y, Xia Y, Tang J, Rocchi P, Qu F, Iovanna J, Peng L.

Org Lett. 2010 Dec 17;12(24):5712-5. doi: 10.1021/ol102537p. Epub 2010 Nov 18.

PMID:
21086980
47.

A novel arylethynyltriazole acyclonucleoside inhibits proliferation of drug-resistant pancreatic cancer cells.

Wang M, Xia Y, Fan Y, Rocchi P, Qu F, Iovanna JL, Peng L.

Bioorg Med Chem Lett. 2010 Oct 15;20(20):5979-83. doi: 10.1016/j.bmcl.2010.08.093. Epub 2010 Aug 21.

PMID:
20829040
48.

RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells.

Papi A, Rocchi P, Ferreri AM, Orlandi M.

Cancer Lett. 2010 Nov 1;297(1):65-74. doi: 10.1016/j.canlet.2010.04.026. Epub 2010 May 26.

PMID:
20510503
49.

Epigenetic modifiers as anticancer drugs: effectiveness of valproic acid in neural crest-derived tumor cells.

Papi A, Ferreri AM, Rocchi P, Guerra F, Orlandi M.

Anticancer Res. 2010 Feb;30(2):535-40.

PMID:
20332466
50.

N-aryltriazole ribonucleosides with potent antiproliferative activity against drug-resistant pancreatic cancer.

Liu Y, Xia Y, Fan Y, Maggiani A, Rocchi P, Qu F, Iovanna JL, Peng L.

Bioorg Med Chem Lett. 2010 Apr 15;20(8):2503-7. doi: 10.1016/j.bmcl.2010.02.104. Epub 2010 Mar 3.

PMID:
20304644

Supplemental Content

Loading ...
Support Center